RNA Therapeutics 2017
In-Person Event
Feb 22 - 23, 2017
London, England, GBSpeakers
OVERVIEW
RNA Therapeutics 2017 is organized by SMi Group and would be held during Feb 22 - 23, 2017 at Copthorne Tara Hotel, London, England, United Kingdom.
8th annual RNA Therapeutics conference will feature a mix of case study-led presentations, panel debates and interactive workshops tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems.
This exciting programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.
Join us next February to expand your scientific horizons on emerging concepts in nanoparticle delivery systems, small activating RNA and 3rd generation antisense technology. Plus, we'll be honing in on under-met areas such as targeted delivery beyond the liver, and offering regulatory guidance on the reporting of clinical data through an exclusive MHRA keynote.
Speakers include :
Nagy Habib, Head of Surgery, Co-Founder, Imperial College Healthcare NHS Trust, MiNA Therapeutics
John Johnston, Clinical Assessor Biologicals and Biotechnology Unit, MHRA
Heinrich Haas, Vice President RNA Formulation and Drug Delivery, BioNTech RNA
Bo Rode Hansen, Global Head of RNA Therapeutics, Roche
Nicole Meisner-Kober, Senior Investigator, RNA Biology, Novartis
Steve Hood, Director, Bioimaging, GSK
David Giljohann, CEO, Exicure
Shai Erlich, Chief Medical Officer and President USA, Quark Pharmaceuticals
Amotz Shemi, CEO, Silenseed
Sanyogitta Puri, Associate Principal Scientist, AstraZeneca
Reasons to attend :
• Discover exciting developments of mRNA and antisense oligonucleotide based therapeutics
• Find out how pharmaceutical and biotech companies are strategically improving drug delivery systems
• Discuss clinical developments and take away key lessons for future developments
• Understand the pharmacokinetic considerations of oligonucleotides and RNA therapies
• Hear how the experts navigate the regulatory landscape
Price :
Conference + Workshop - GBP 2098,
Conference only - GBP 1499
8th annual RNA Therapeutics conference will feature a mix of case study-led presentations, panel debates and interactive workshops tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems.
This exciting programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.
Join us next February to expand your scientific horizons on emerging concepts in nanoparticle delivery systems, small activating RNA and 3rd generation antisense technology. Plus, we'll be honing in on under-met areas such as targeted delivery beyond the liver, and offering regulatory guidance on the reporting of clinical data through an exclusive MHRA keynote.
Speakers include :
Nagy Habib, Head of Surgery, Co-Founder, Imperial College Healthcare NHS Trust, MiNA Therapeutics
John Johnston, Clinical Assessor Biologicals and Biotechnology Unit, MHRA
Heinrich Haas, Vice President RNA Formulation and Drug Delivery, BioNTech RNA
Bo Rode Hansen, Global Head of RNA Therapeutics, Roche
Nicole Meisner-Kober, Senior Investigator, RNA Biology, Novartis
Steve Hood, Director, Bioimaging, GSK
David Giljohann, CEO, Exicure
Shai Erlich, Chief Medical Officer and President USA, Quark Pharmaceuticals
Amotz Shemi, CEO, Silenseed
Sanyogitta Puri, Associate Principal Scientist, AstraZeneca
Reasons to attend :
• Discover exciting developments of mRNA and antisense oligonucleotide based therapeutics
• Find out how pharmaceutical and biotech companies are strategically improving drug delivery systems
• Discuss clinical developments and take away key lessons for future developments
• Understand the pharmacokinetic considerations of oligonucleotides and RNA therapies
• Hear how the experts navigate the regulatory landscape
Price :
Conference + Workshop - GBP 2098,
Conference only - GBP 1499
KEY DATES
22 Feb, 2017
Event Start Date
23 Feb, 2017
Event End Date
SPECIALITIES
BiotechnologyResearch and Clinical ResearchSUGGESTED HOTELS
CONFERENCE VENUE
Copthorne Tara HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links